DUBLIN, Sept. 20, 2019 /PRNewswire/ -- The "Anatomic Pathology Market Research Report: By Product, type, technique, Application, End-User, Regional Insight - Global Industry Analysis and Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global anatomic pathology market is projected to attain a size of $24.3 billion by 2024, progressing at a 5.8% CAGR during the forecast period.
The increasing prevalence of chronic diseases, developments in technology, and surging geriatric population are some of the major reasons behind the growth of the market. On the basis of application, the market is categorized into drug discovery, disease diagnosis, and others. Out of these, the disease diagnosis category is expected to hold the largest share of more than 65.0% in the market by 2024.
This is attributed to the surging aging population and rising number of patients suffering from the chronic ailments. When segmented by end user, the anatomic pathology market is classified into diagnostic laboratories, ambulatory surgical centers, hospitals and clinics, and academic and research organizations. Among these, in 2018, diagnostic laboratories led the market with a share of 45.8%, followed by hospitals and clinics that held a 31.4% share. The reason behind this is that these laboratories are less expensive as compared to hospitals and clinics.
The Asia-Pacific (APAC) anatomic pathology market is predicted to witness the fastest growth at a 6.7% CAGR during the forecast period. The key factors responsible for such rapid progress would be the acceptance of personalized medicine, growing number of chronic ailment patients, increasing investment in diagnostic research by non-government and government organizations, and entry of established players in the region. The increasing entrance rate of international players in the market is helping in better availability of advanced and innovative anatomic pathology consumables and instruments in APAC.
For instance, in January 2019, Nichirei Bioscience (one of the leading suppliers of diagnostic and biological products in Japan) collaborated with Biocartis Group NV for the product registration and exclusive distribution of molecular diagnostic (MDx) oncology tests, developed by Biocartis, in Japan, which work on the sample-to-result Idylla platform, which is fully automated, Under this, Nichirei Bioscience agreed to get the regulatory approval of the Japanese Ministry of Health, Labour, and Welfare for Idylla MDx oncology tests. After the registration, Nichirei Bioscience aims to provide Biocartis' Idylla platform to 2,000 pathology laboratories within its commercial network in Japan.
The key players operating in the anatomic pathology market are gearing up to introduce innovative solutions to improve their market presence.
For instance, in February 2019, Quest Diagnostics Inc., a U.S.-based diagnostic information services provider, purchased the clinical laboratory services unit of Boyce & Bynum Pathology Laboratories (BBPL), a leading supplier of diagnostic and clinical laboratory services in the Midwest. The acquisition is aimed at offering a larger portfolio of anatomic pathology and innovative clinical laboratory services to providers and patients throughout the region.
Key Topics Covered:
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Product
188.8.131.52.1.2 Stains and dyes
184.108.40.206.1 Tissue processors
220.127.116.11.2 Slide stainers
4.1.2 By Test Type
18.104.22.168 Surgical pathology
4.1.3 By Technique
22.214.171.124 Special staining
126.96.36.199 Electron microscopy
188.8.131.52 Genetic testing
4.1.4 By Application
184.108.40.206 Disease diagnosis
220.127.116.11 Drug discovery
4.1.5 By End User
18.104.22.168 Diagnostic laboratories
22.214.171.124 Hospitals and clinics
126.96.36.199 Ambulatory surgical centers
188.8.131.52 Academic and research organizations
4.2 Market Dynamics
184.108.40.206 Adoption of new technologies
220.127.116.11 Increasing number of collaborations and acquisitions
18.104.22.168 Increasing incidence of chronic diseases
22.214.171.124 Rising geriatric population
126.96.36.199 Advancements in technologies
188.8.131.52 Increasing market consolidation
184.108.40.206 Lack of monetary support from healthcare insurance providers
220.127.116.11 Inability of underdeveloped countries to adopt digital anatomic pathology
18.104.22.168 Increasing medical tourism in APAC
22.214.171.124 Emerging economies across the world
4.3 Porter's Five Forces Analysis
4.4 Technological Advancements
4.5 Regulatory Framework
4.6 Pricing Analysis
Chapter 5. Global Market Size and Forecast
5.1 By Product
5.1.1 Consumables Market by Type
126.96.36.199 Reagents market by type
5.1.2 Instruments Market by Type
5.2 By Test Type
5.3 By Technique
5.4 By Application
5.4.1 Disease Diagnosis Market by Type
5.5 By End User
5.6 By Region
Chapter 6. North America Market Size and Forecast
Chapter 7. Europe Market Size and Forecast
Chapter 8. APAC Market Size and Forecast
Chapter 9. LATAM Market Size and Forecast
Chapter 10. MEA Market Size and Forecast
Chapter 11. Competitive Landscape
11.1 Company Benchmarking Based on Offerings
11.2 Technique Benchmarking of Key Players
11.3 Global Strategic Developments of Key Players
11.3.1 Acquisitions and Collaborations
11.3.2 New Product Launches and Patent Approvals
Chapter 12. Company Profiles
- F. Hoffmann-La Roche Ltd.
- Quest Diagnostics Incorporated
- Bio-Rad Laboratories Inc.
- Agilent Technologies Inc.
- Neogenomics Laboratories Inc.
- Abbott Laboratories
- Sakura Finetek USA Inc.
- OriGene Technologies Inc.
- Biocare Medical LLC
- Sonic Healthcare Limited
- DTM Print GmBH
- Caris Life Sciences Inc.
- Sunquest Information Systems Inc.
- Inform Diagnostics Inc.
- Interpath Laboratory Inc.
For more information about this report visit https://www.researchandmarkets.com/r/bvdu0a
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716